Literature DB >> 30533105

Cardiogenic shock due to takotsubo cardiomyopathy associated with serotonin syndrome.

Hojo Sasaki1, Kazuhiko Yumoto1, Taikan Nanao2, Hideo Nishizawa2, Syuhei Funada1, Hajime Aoki1, Kenichi Kato1.   

Abstract

A 65-year-old woman, with valvular heart disease, atrial fibrillation, and depression, presented to the emergency room due to dyspnea with shock state accompanied by agitation. An electrocardiogram showed ST segment elevation in leads II, III, aVF, I, aVL, and V4-6. An echocardiography revealed extensive akinesis in the apex, but hyperkinesis in the base, with apical ballooning appearance. An emergent coronary angiography showed no obstructive disease. The patient required intubation under mechanical ventilator, and an intra-aortic balloon pump to recover from shock state. She had been taking maprotiline, a tetracyclic antidepressant, and had added dextromethorphan, a cough suppressant, just before admission. The patient was diagnosed with takotsubo cardiomyopathy associated with serotonin syndrome due to serotonergic drug interactions. After discontinuation of these drugs and administration of serotonin antagonist under mechanical supportive care, she became hemodynamically stable. Apical ballooning was completely resolved 2 weeks later, and she was discharged well. We diagnosed serotonin syndrome manifesting as excessive serotonin toxicity that resulted in a hyperserotonergic and hyperadrenergic state, causing takotsubo cardiomyopathy. Here, we report a case of takotsubo cardiomyopathy associated with serotonin syndrome. This case suggests that serotonin syndrome should be recognized promptly and complications, including takotsubo cardiomyopathy, need to be treated appropriately. <Learning objective: We must closely monitor serotonergic agents because serotonin syndrome can occur from a combination some serotonergic drugs, even when each is used at a therapeutic dose. Serotonin syndrome can lead to not only serotonergic but also hyperadrenergic state that may be a trigger of takotsubo cardiomyopathy. Serotonin syndrome should be diagnosed surely to ensure the prompt initiation of the treatment included discontinuation of the precipitating drugs because the disease occasionally progresses rapidly to fatal condition.>.

Entities:  

Keywords:  Cardiogenic shock; Serotonin syndrome; Takotsubo cardiomyopathy

Year:  2012        PMID: 30533105      PMCID: PMC6269404          DOI: 10.1016/j.jccase.2012.07.011

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  5 in total

1.  Slow on the Uptake, Progression to Heartbreak.

Authors:  Ashley K Binder; John P Haydek; Siddhant Parihar; Chelsea E Modlin; Manasi Tannu; Amalia Aldredge; Viranuj Sueblinvong
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

2.  Takotsubo cardiomyopathy associated with serotonin syndrome in a patient with stroke: A case report.

Authors:  Sung Ho Jang; Jong-Ho Nam; Jun Lee; Min Cheol Chang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 3.  Takotsubo Cardiomyopathy: Medical and Psychiatric Aspects. Role of Psychotropic Medications in the Treatment of Adults with "Broken Heart" Syndrome.

Authors:  Valeriy Zvonarev
Journal:  Cureus       Date:  2019-07-19

4.  Clinical and Angiographic Features in Three COVID-19 Patients with Takotsubo Cardiomyopathy. Case Report.

Authors:  Wolfgang Hoepler; Marianna Theresia Traugott; Guenter Christ; Reinhard Kitzberger; Erich Pawelka; Mario Karolyi; Tamara Seitz; Sebastian Baumgartner; Hasan Kelani; Christoph Wenisch; Hermann Laferl; Alexander Zoufaly; Lukas Weseslindtner; Stephanie Neuhold
Journal:  SN Compr Clin Med       Date:  2021-01-06

Review 5.  Update of Takotsubo cardiomyopathy: Present experience and outlook for the future.

Authors:  Anastasiia V Bairashevskaia; Sofiya Y Belogubova; Mikhail R Kondratiuk; Daria S Rudnova; Susanna S Sologova; Olga I Tereshkina; Esma I Avakyan
Journal:  Int J Cardiol Heart Vasc       Date:  2022-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.